Edition:
India

People: Impax Laboratories Inc (IPXL.OQ)

IPXL.OQ on NASDAQ Stock Exchange Global Select Market

19.60USD
16 Feb 2018
Change (% chg)

$0.20 (+1.03%)
Prev Close
$19.40
Open
$19.35
Day's High
$20.20
Day's Low
$19.23
Volume
176,718
Avg. Vol
274,671
52-wk High
$25.70
52-wk Low
$7.80

Terreri, Peter 

Mr. Peter R. Terreri CPA. is Independent Director of Impax Laboratories Inc. He is President, Chief Executive Officer and director of CGM, Inc. a manufacturing company that he has owned and operated since 2000. He previously served as Senior Vice President and Chief Financial Officer of Teva Pharmaceuticals USA from 1985 through 2000 and as an auditor at PricewaterhouseCoopers LLP from 1981 to 1984. Mr. Terreri received his B.S. in Accounting from Drexel University and has been a certified public accountant since 1981.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 132,694
Long-Term Incentive Plans, USD --
All Other, USD 224,180
Fiscal Year Total, USD 356,874

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Burr

389,374

Paul Bisaro

--

Bryan Reasons

2,248,520

Douglas Boothe

2,499,380

Michael Nestor

2,000,560

Robert Stewart

--
As Of  31 Dec 2016